Kestra Advisory Services’s RenovoRx RNXT Stock Holding History

Kestra Advisory Services’s Portfolio RNXT Stock Details RNXT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$34.8K	Hold	35,520	–	–	﹤0.01%	3223
2026 Q1	$35.9K	Hold	35,520	–	–	﹤0.01%	3070
2025 Q4	$29.8K	Hold	35,520	–	–	﹤0.01%	4296
2025 Q3	$45.1K	Hold	35,520	–	–	﹤0.01%	2863
2025 Q2	$46.7K	Hold	35,520	–	–	﹤0.01%	2774
2025 Q1	$35.2K	Hold	35,520	–	–	﹤0.01%	2669
2024 Q4	$45.8K	Hold	35,520	–	–	﹤0.01%	2611
2024 Q3	$37.7K	Buy	+35,520	New	+$39.8K	﹤0.01%	2511

Other funds holding RNXT

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

WANY

Wealthspire Advisors (New York) New York $18.2B AUM 21.48% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

CPIG

Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return

Northwestern Mutual Wealth Management Milwaukee, Wisconsin $187B AUM 21.7% 1-Year Est. Return

Kestra Advisory Services's RNXT Position: Q2 2026 in Review

Kestra Advisory Services held its RenovoRx (RNXT) position steady in Q2 2026 at 35,520 shares worth $34.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3223.

Kestra Advisory Services first reported a position in RNXT in Q3 2024 and has held it in 8 quarters since. The position peaked at $46.7K in Q2 2025. 28 funds tracked by Wall St. Rank hold RNXT as of Q2 2026.

Kestra Advisory Services held 35,520 shares of RenovoRx worth $34.8K as of Q2 2026.
Kestra Advisory Services left its RenovoRx share count unchanged in Q2 2026.
RenovoRx made up ﹤0.01% of Kestra Advisory Services's portfolio in Q2 2026, its #3223 holding.
Kestra Advisory Services first reported a position in RenovoRx in Q3 2024 and has held it in 8 quarters since.
Kestra Advisory Services's RenovoRx position peaked at $46.7K in Q2 2025.
28 funds tracked by Wall St. Rank held RenovoRx as of Q2 2026.

Based on Kestra Advisory Services's 13F filing for Q2 2026, filed 28 Jul 2026.